Novasep Solutions for Pharmaceutical Applications

Novasep supplies tailored solutions to pharmaceutical companies from process development to commercial manufacturing, through its two business divisions Novasep Process and Novasep Synthesis.

Novasep offers production, synthesis, purification and separation solutions to the pharmaceutical industry for Active Pharmaceutical Ingredients, highly potent products and advanced intermediates.

By offering both purification/production equipment and outsourcing/manufacturing services, Novasep supports its customers of the pharmaceutical industry in their decisive tactical or strategic choices.

 

Novasep's customers have a real choice: to in-source their production at optimized costs and performance or to outsource it at Novasep in state-of-the-art technological and economical conditions.

Synthesis and Production Solutions for Pharmaceuticals

Novasep Synthesis offers outsourcing solutions to pharmaceutical companies via its exclusive synthesis capacities and expertise.

More about Novasep synthesis and production applications for pharmaceuticals.

More about Novasep exclusive synthesis services.

Purification and Separation Solutions for Pharmaceuticals

Novasep Process offers purifications systems and services for pharmaceuticals.

More about Novasep purification and production applications for pharmaceuticals.

More about Novasep purification systems and services.

Long-term Partnership

Benefit and Advantages

Custom designed Solutions

Big, mid-sized and emerging pharma companies share the same needs to meet quality, quantity and timeline challenges but these are different and depend on their business model.

We understand these and adapt to our customers' concerns.

Mastering an extensive range of technologies (hazardous chemistry, chiral technologies, highly potent API synthesis, chromatography, crystallization, membrane technologies.) Novasep guarantees that the appropriate solution is applied to your pharmaceutical molecules.

Cost Effective and Innovative Processes

Novasep's unique ability to combine synthesis and process expertise is one of our main assets to propose competitively priced solutions for pharmaceutical in- or outsourcing.

When cost matters, Novasep can also develop second generation, innovative processes for the cost effective manufacture of commercial small molecules, whether they are chiral or not, intermediates or APIs, peptides, brand or generic drugs.

Achievements and References

Novasep's expertise has supported the development of numerous molecules and APIs and contributed to their launch on the market.

Today, the top 20 pharmaceutical groups of the world, as well as medium size pharmaceutical and fine chemical companies and many biotech companies are customers of Novasep.